Skip to main content
![[<sup>177</sup>Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial](https://jnm.snmjournals.org/sites/default/files/styles/medium/public/externals/8c6d24f221be7bf3ada392194e8442bd.jpg?itok=Z5f9BpLP)